Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
CNMD Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CNMD Stock 12 Month Forecast
Average Price Target
$64.50
▲(16.87% Upside)
| Highest Price Target$68.00 | Average Price Target$64.50 | Lowest Price Target$61.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$60→$61
Buy
10.53%
Upside
Reiterated
08/13/25
Piper Sandler
$80→$68
Buy
23.21%
Upside
Reiterated
07/31/25
Unknown Analyst
JefferiesNot Ranked
Jefferies
―
Hold
―
Reiterated
05/02/25
We maintain our Hold rating on CNMD.
J.P. Morgan
$70→$58
Hold
5.09%
Upside
Reiterated
05/01/25
Stifel Nicolaus
$55
Hold
-0.34%
Downside
Reiterated
05/01/25
Wells Fargo
$70→$57
Hold
3.28%
Upside
Reiterated
04/30/25
Bank of America Securities
$85→$80
Hold
44.95%
Upside
Assigned
01/27/25
Cautious Optimism for Conmed Amidst Strategic Realignment and Reset ExpectationsWe think this is the first step to getting the stock to work again. Once Street numbers reset, then CNMD will have a more realistic bar to execute against. And multiples tend to expand when estimates move higher (CNMD’s multiple has compressed over last year as Street estimates kept falling). We “level set” our model; 2025 EPS $4.52; 2026 EPS $5.21 We update our CNMD model to reflect CNMD’s new medium-term view. Our 2025 EPS goes to $4.52 (vs $5.00 prior) and our 2026 EPS goes to $5.21 (vs $5.85 prior). We model total CNMD organic revenue growth of 5.3% in 2025 and 6.4% in 2026. We model 50bps of GM expansion in 2025 and 80bps in 2026. We model 70bps of operating margin expansion in 2025 and 100bps in 2026.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$60→$61
Buy
10.53%
Upside
Reiterated
08/13/25
Piper Sandler
$80→$68
Buy
23.21%
Upside
Reiterated
07/31/25
Unknown Analyst
JefferiesNot Ranked
Jefferies
―
Hold
―
Reiterated
05/02/25
We maintain our Hold rating on CNMD.
J.P. Morgan
$70→$58
Hold
5.09%
Upside
Reiterated
05/01/25
Stifel Nicolaus
$55
Hold
-0.34%
Downside
Reiterated
05/01/25
Wells Fargo
$70→$57
Hold
3.28%
Upside
Reiterated
04/30/25
Bank of America Securities
$85→$80
Hold
44.95%
Upside
Assigned
01/27/25
Cautious Optimism for Conmed Amidst Strategic Realignment and Reset ExpectationsWe think this is the first step to getting the stock to work again. Once Street numbers reset, then CNMD will have a more realistic bar to execute against. And multiples tend to expand when estimates move higher (CNMD’s multiple has compressed over last year as Street estimates kept falling). We “level set” our model; 2025 EPS $4.52; 2026 EPS $5.21 We update our CNMD model to reflect CNMD’s new medium-term view. Our 2025 EPS goes to $4.52 (vs $5.00 prior) and our 2026 EPS goes to $5.21 (vs $5.85 prior). We model total CNMD organic revenue growth of 5.3% in 2025 and 6.4% in 2026. We model 50bps of GM expansion in 2025 and 80bps in 2026. We model 70bps of operating margin expansion in 2025 and 100bps in 2026.
Best Analysts Covering Conmed
1 Month
xxx
Success Rate
6/19 ratings generated profit
Average Return
-1.44%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 31.58% of your transactions generating a profit, with an average return of -1.44% per trade.
3 Months
xxx
Success Rate
7/19 ratings generated profit
Average Return
-4.05%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 36.84% of your transactions generating a profit, with an average return of -4.05% per trade.
1 Year
Success Rate
5/19 ratings generated profit
Average Return
-14.75%
reiterated a buy rating 15 days ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -14.75% per trade.
2 Years
xxx
Success Rate
1/19 ratings generated profit
Average Return
-27.67%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 5.26% of your transactions generating a profit, with an average return of -27.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CNMD Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
11
10
7
8
8
Hold
6
7
5
4
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
17
12
12
9
Each month's total comprises the sum of three months' worth of ratings.
CNMD Financial Forecast
CNMD Stock Forecast FAQ
What is CNMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Conmed’s 12-month average price target is 64.50.
What is CNMD’s upside potential, based on the analysts’ average price target?
Conmed has 16.87% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CNMD a Buy, Sell or Hold?
Conmed has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Conmed’s price target?
The average price target for Conmed is 64.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $68.00 ,the lowest forecast is $61.00. The average price target represents 16.87% Increase from the current price of $55.19.
The highest analyst price target is $68.00 ,the lowest forecast is $61.00. The average price target represents 16.87% Increase from the current price of $55.19.
What do analysts say about Conmed?
Conmed’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of CNMD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.